-
Something wrong with this record ?
Advances in cytomegalovirus-preventive strategies in solid organ transplantation: defending pre-emptive therapy
T. Reischig,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
NLK
ProQuest Central
from 2003-06-01 to 2014-09-30
Nursing & Allied Health Database (ProQuest)
from 2003-06-01 to 2014-09-30
Health & Medicine (ProQuest)
from 2003-06-01 to 2014-09-30
PubMed
22149614
DOI
10.1586/eri.11.156
Knihovny.cz E-resources
- MeSH
- Acyclovir analogs & derivatives therapeutic use MeSH
- Antiviral Agents therapeutic use MeSH
- Cytomegalovirus Infections prevention & control MeSH
- Ganciclovir analogs & derivatives therapeutic use MeSH
- Immunosuppressive Agents therapeutic use MeSH
- Clinical Protocols MeSH
- Humans MeSH
- Opportunistic Infections prevention & control MeSH
- Randomized Controlled Trials as Topic MeSH
- Organ Transplantation MeSH
- Valine analogs & derivatives therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Prevention of cytomegalovirus (CMV) infection is an important part of clinical care provided to patients after solid organ transplantation. While the optimal preventive strategy has not been defined, most centers rely on universal prophylaxis or pre-emptive therapy. This article comments on recent studies designed to identify strategies that effectively reduce the incidence of late-onset CMV disease as the main problem associated with prophylaxis, and on recent data regarding the development of CMV-specific immunity depending on the CMV-preventive regimen used. Despite an apparent trend to prefer prophylaxis in clinical practice, this approach does not seem to be based on robust evidence.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12034844
- 003
- CZ-PrNML
- 005
- 20121123094801.0
- 007
- ta
- 008
- 121023s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1586/eri.11.156 $2 doi
- 035 __
- $a (PubMed)22149614
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Reischig, Tomáš $u Department of Internal Medicine I, Charles University Medical School and Teaching Hospital, Alej Svobody 80, 304 60 Pilsen, Czech Republic. reischig@fnplzen.cz
- 245 10
- $a Advances in cytomegalovirus-preventive strategies in solid organ transplantation: defending pre-emptive therapy / $c T. Reischig,
- 520 9_
- $a Prevention of cytomegalovirus (CMV) infection is an important part of clinical care provided to patients after solid organ transplantation. While the optimal preventive strategy has not been defined, most centers rely on universal prophylaxis or pre-emptive therapy. This article comments on recent studies designed to identify strategies that effectively reduce the incidence of late-onset CMV disease as the main problem associated with prophylaxis, and on recent data regarding the development of CMV-specific immunity depending on the CMV-preventive regimen used. Despite an apparent trend to prefer prophylaxis in clinical practice, this approach does not seem to be based on robust evidence.
- 650 _2
- $a acyklovir $x analogy a deriváty $x terapeutické užití $7 D000212
- 650 _2
- $a antivirové látky $x terapeutické užití $7 D000998
- 650 _2
- $a klinické protokoly $7 D002985
- 650 _2
- $a cytomegalovirové infekce $x prevence a kontrola $7 D003586
- 650 _2
- $a ganciklovir $x analogy a deriváty $x terapeutické užití $7 D015774
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunosupresiva $x terapeutické užití $7 D007166
- 650 _2
- $a oportunní infekce $x prevence a kontrola $7 D009894
- 650 _2
- $a transplantace orgánů $7 D016377
- 650 _2
- $a randomizované kontrolované studie jako téma $7 D016032
- 650 _2
- $a valin $x analogy a deriváty $x terapeutické užití $7 D014633
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 773 0_
- $w MED00174403 $t Expert review of anti-infective therapy $x 1744-8336 $g Roč. 10, č. 1 (2012), s. 51-61
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22149614 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20121123094824 $b ABA008
- 999 __
- $a ok $b bmc $g 956854 $s 792341
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 10 $c 1 $d 51-61 $i 1744-8336 $m Expert review of anti-infective therapy $n Expert Rev Anti Infect Ther $x MED00174403
- LZP __
- $a Pubmed-20121023
